Primary tabs

Other Access

The information on this page (the dataset metadata) is also available in these formats.

JSON RDF

via the DKAN API

A Randomised Double-Blind Placebo-Controlled Dose-Ranging Study to Determine the Efficacy Safety and Tolerability of AZD7295 in Combination with Pegylated Interferon alpha-2a and Ribavirin in Patients with Chronic Hepatitis C Virus Genotype 1b...

To determine the Rapid Virologic Response RVR of multiple oral doses of AZD7295 in conjunction with standard of care SoC in patients with chronic hepatitis C virus genotype 1b infection

FieldValue
Modified
2019-08-31
Release Date
2018-03-19
Identifier
26a39c32-c299-41b2-8c8b-91d804ca7606
License
Public Access Level
Public